Skip to main content

Mortality Increased for Infants, Under 5s With HIV Receiving Antiretrovirals

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 1, 2023.

By Elana Gotkine HealthDay Reporter

THURSDAY, Nov. 30, 2023 -- More infants and children aged younger than 5 years with HIV receiving antiretroviral therapy (ART) die compared with those aged 5 years and older receiving ART, according to research published in the Dec. 1 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Nickolas T. Agathis, M.D., from the CDC in Atlanta, and colleagues compared mortality and related clinical measures among infants younger than 1 year and children aged 1 to 4 years living with HIV and receiving ART compared to those of older persons aged 5 to 14, 15 to 49, and 50 years and older living with HIV and receiving ART.

An average of 11,980 infants aged younger than 1 year and 105,510 children aged 1 to 4 years were receiving ART each quarter during October 2020 to September 2022; of these, 4.9 and 2.5 percent, respectively, were reported to have died annually. The researchers found that compared with the proportions of persons aged 5 years and older receiving ART, the proportions of infants and children who died ranged from four to nine times higher in infants aged younger than 1 year and from two to five times higher in children aged 1 to 4 years. The proportions of children aged younger than 5 years living with HIV who experienced interruptions in treatment were also higher compared with persons aged 5 years and older, while lower proportions were seen with a documented HIV viral load result or suppressed viral load.

"Prioritizing and optimizing HIV and general health services for children aged <5 years living with HIV receiving ART might help address the disproportionately poorer outcomes they experience," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Cognitive Impairment Still Seen in Children, Teens With HIV

TUESDAY, April 30, 2024 -- Cognitive impairment persists in children and adolescents living with HIV even in the era of antiretroviral therapy (ART), according to research...

Pandemic Reignited Debate Regarding Physician's Obligation to Treat

MONDAY, April 29, 2024 -- There was a surge in ethics literature during COVID-19 advocating for the ethical acceptability of physicians refusing to treat, according to a study...

Coronary Artery Vessel Wall Thickness Increased for People Living With HIV

TUESDAY, April 16, 2024 -- Asymptomatic people living with HIV (PLWH) with a low risk for cardiovascular disease have increased coronary artery vessel wall thickness (VWT)...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.